Various prospective reports have shown relationships between serum ALT levels and the risk of cardiovascular diseases, type 2 diabetes mellitus, vascular and nonvascular mortality, and all-cause mortality outcomes [30]. The gene discussed is GPT; the disease is diabetes mellitus.